Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Acquires 12,445 Shares

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw bought 12,445 shares of Retractable Technologies stock in a transaction on Monday, January 27th. The stock was acquired at an average cost of $0.81 per share, for a total transaction of $10,080.45. Following the acquisition, the chief executive officer now owns 15,019,308 shares in the company, valued at approximately $12,165,639.48. This represents a 0.08 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Retractable Technologies Price Performance

Shares of Retractable Technologies stock traded up $0.01 during midday trading on Tuesday, hitting $0.80. 47,055 shares of the company traded hands, compared to its average volume of 120,809. The firm’s fifty day moving average price is $0.68 and its 200-day moving average price is $0.82. The stock has a market cap of $23.95 million, a price-to-earnings ratio of -1.48 and a beta of 1.94. Retractable Technologies, Inc. has a 12 month low of $0.56 and a 12 month high of $1.34. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57.

Analyst Upgrades and Downgrades

Separately, StockNews.com initiated coverage on Retractable Technologies in a research note on Wednesday, January 22nd. They issued a “hold” rating on the stock.

Institutional Trading of Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new position in Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is currently owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.